Live Breaking News & Updates on Brainstorm Cell

Stay updated with breaking news from Brainstorm cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Brainstorm Cell Therapeutics (NASDAQ:BCLI) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a research note published on Friday. The firm issued a hold rating on the biotechnology company’s stock. Brainstorm Cell Therapeutics Stock Down 7.0 % BCLI stock opened at $0.54 on Friday. Brainstorm Cell Therapeutics has a 52-week low of $0.13 and […] ....

Brainstorm Cell Therapeutics Company Profile , Brainstorm Cell Therapeutics Inc , Securities Exchange Commission , Kingswood Wealth Advisors , Brainstorm Cell Therapeutics , Free Report , Cell Therapeutics Stock Down , Cell Therapeutics , Get Free Report , Brainstorm Cell , Wealth Advisors , Cell Therapeutics Inc , Brainstorm Cell Therapeutics Daily ,

BCLI Stock Earnings: Brainstorm Cell Reported Results for Q1 2024

BCLI Stock Earnings: Brainstorm Cell Reported Results for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Brainstorm Cell , Place Earnings ,

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Short Interest Update

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI – Get Free Report) was the recipient of a significant increase in short interest in April. As of April 15th, there was short interest totalling 1,990,000 shares, an increase of 48.5% from the March 31st total of 1,340,000 shares. Based on an average daily volume of 987,100 shares, the short-interest […] ....

Securities Exchange Commission , Brainstorm Cell Therapeutics Inc , Kingswood Wealth Advisors , Brainstorm Cell Therapeutics , Get Free Report , Cell Therapeutics , Brainstorm Cell , Wealth Advisors , Free Report , Cell Therapeutics Inc , Brainstorm Cell Therapeutics Daily , Nasdaq Bcli ,